| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | Freeman Kevin D56 | Director | Buy | 5,000 | $1.96 | $9,806.00 | +11.1% | -15.4% | -43.3% | |
| Jan 14, 2022 | Zordani Richard A. Jr.52 | Director | Buy | 5,000 | $2.02 | $10,100.00 | +34.3% | -13.9% | -43.6% | |
| Jan 11, 2022 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.10 | $21,000.00 | -0.2% | -27.9% | -46.1% | |
| Dec 6, 2021 | Freeman Kevin D56 | Director | Buy | 5,000 | $2.28 | $11,400.00 | +11.1% | -25.8% | -49.6% | |
| Dec 6, 2021 | Freeman Kevin D56 | Director | Buy | 5,000 | $2.34 | $11,700.00 | +12.5% | -25.8% | -49.6% | |
| Dec 2, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.37 | $23,700.00 | -0.2% | -25.3% | -50.2% | |
| Nov 1, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $3.19 | $31,900.00 | -0.2% | -41.0% | -57.5% | |
| Oct 29, 2021 | Freeman Kevin D56 | Director | Buy | 2,000 | $3.17 | $6,340.00 | +5.3% | -42.6% | -56.2% | |
| Oct 21, 2021 | Freeman Kevin D56 | Director | Buy | 2,000 | $3.19 | $6,380.00 | +5.6% | -37.6% | -53.4% | |
| Oct 19, 2021 | Freeman Kevin D56 | Director | Buy | 3,000 | $3.37 | $10,106.70 | +9.1% | -41.9% | -53.6% |